Peritoneal and pleural ports for management of refractory ascites and pleural effusions: Assessment of impact on patient quality of life and hospice/home nursing care

Journal of Palliative Medicine

Volumn 12, Issue 9, 2009, Pages 811-817

  Monsky, Wayne L ^a   Yoneda, Ken Y ^a   MacMillan, John ^a   Deutsch, Larry Stuart ^a   Dong, Paul ^a   Hourigan, Helen ^a   Schwartz, Yvonne ^b   Magee, Stacey ^b   Duffield, Curtis ^a   Boak, Tammy ^a   Cernilia, James ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BLEOMYCIN; CEFAZOLIN; METRONIDAZOLE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; ASCITES; ASPIRATION CATHETER; CATHETER ASPIRATION; CATHETER OCCLUSION; CELLULITIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; ECHOGRAPHY; FLUOROSCOPY; FOLLOW UP; HEALTH CARE COST; HOSPICE CARE; HUMAN; PERITONEAL CATHETER; PLEURA EFFUSION; PLEURAL PORT CATHETER; PLEURODESIS; PNEUMOTHORAX; QUALITY OF LIFE; QUESTIONNAIRE; SAFETY; SUBCUTANEOUS EMPHYSEMA; SUBCUTANEOUS TISSUE; TUMOR SEEDING; FEMALE; HEALTH STATUS INDICATOR; HOME CARE; INDWELLING CATHETER; INFUSION; MALE; MIDDLE AGED; NURSING; PLEURAL EFFUSION; PROCEDURES; PSYCHOMETRY; RETROSPECTIVE STUDY; TREATMENT FAILURE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ASCITES; CATHETERS, INDWELLING; FEMALE; HEALTH STATUS INDICATORS; HOME NURSING; HOSPICE CARE; HUMANS; INFUSIONS, PARENTERAL; MALE; MIDDLE AGED; PLEURAL EFFUSION; PLEURODESIS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 70350099327     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2009.0061     Document Type: Article

References (26)

1. Lacy JH, Wieman TJ, Shively EH: Management of malignant ascites. Surg Obstet Gynecol 1984;159:397-412.
2. Yoneda KY, Mathur PN, Gasparini S: The evolving role of interventional pulmonary in the interdisciplinary approach to the staging and management of lung cancer. Part III: Diagnosis and management of malignant pleural effusions. Clin Lung Cancer 2007;8:535-1447
3. Burrows CM, Mathews WC, Colt HG: Predicting survival in patients with recurrent symptomatic malignant pleural effusions: An assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease. Chest 2000;117:73-78.
4. Antony VB, Loddenkemper R, Astoul RP, Boutin C, Goldstraw P, Hott J, Rodriguez Panadero F, Sahn SA: Management of malignant pleural effusions. Eur Respir J 2001;18: 402-419.
5. Daniel C, Kriegel I, Di Maria S Patrubani G, Levesque R, Livartowski A, Esteve M: Use of a pleural implantable access system for the management of malignant pleural effusion: The Institute Curie experience. Ann Thorac Surg 2007;84: 1367-1370.
6. Inan I, De Sousa S, Myers PO, Bouclier B, Dietrich PY, Hagen ME, Morel P: Management of malignant pleural effusion and ascites by a triple access multi perforated large diameter catheter port system. World J Surg Oncol 2008:6:85.
7. Lee YC, Baumann MH, Maskell NA, Waterer GW, Eaton TE, Davies RJ, Heffner JE, Light RW: Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists. Chest 2003;124:2229-2238.
8. Dresler CM, Olak J, Herndon JE, Richards WG, Scalzetti E, Fleishman SB, Kernstine KH, Demmy T, Jablons DM, Kohman L, Daniel TM, Haasler GB, Sugarbaker DJ; Cooperative Groups Cancer and Leukemia Group B; Eastern Cooperative Oncology Group; North Central Cooperative Oncology Group; Radiation Therapy Oncology Group: Phase III inter-group study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 2005;127: 909-915.
9. Garrison RN, Kaelin LD, Galloway RH, Heuser LS: Malignant ascites: Clinical and experimental observations. Ann Surg 1986;203:644-651.
10. Ayantunde AA, Parsons SL: Pattern and prognostic factors in patients with malignant ascites: A retrospective study. Ann. Oncol 2007;18:945-949.
11. Runyon BA: Paracentesis of ascitic fluid: A safe procedure. Arch Intern Med 1986;146:2259-2261.
12. Belfort MA, Stevens PJ, DeHaek K, Soeters R, Krige JE: A new approach to the management of malignant ascites: A permanently implanted abdominal drain. Eur J Surg Oncol 1990;16:47-53.
13. Smith EM, Jayson GC: The current and future management of malignant ascites. Clin Oncol 2003;15:59-72.
14. Tremblay A, Michaud G: Single-center experience with 250 tunneled pleural catheter insertions for malignant pleural effusion. Chest 2006;129:362-368.
15. Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D: Development of a disease specific questionnaire to measure health related QOL in patients with chronic liver disease. Gut 1999;45:295-300.
16. Detmar SB, Muller MJ, Schornagel JH Wever LD, Aaronson NK: Health related QOL assessments and patient-physician communication: A randomized control trial. JAMA 2002; 228:3027-3034.
17. Development of the World Health Organization WHOQOLBREF quality of life assessment. The WHOQOL Group. Psychol Med 1998;28:551-559.
18. Aaronson NK: QOL: What is it? How should it be measured? Oncology 1988;2:69-76.
19. McGee H: Quality of life. In: Kaptein AD, Weinman J (eds): Health Psychology. New York: Blackwell Publishing Ltd., 2004, p. 234.
20. Velikova G, Booth L, Smith AB Brown PM, Lynch P, Brown JM, Selby PJ.: Measuring QOL in routine oncology practice improves communication and patient well being: a randomized controlled trial. J Clin Oncol 2004;22:714-724.
21. Gutteling JJ, deMan RA, Busschbach JJV, Darlington AS: Overview of Research on health related QOL in patients with chronic liver disease. Neth J Med 2007;65;227-233.
22. Sabatelli FW, Glassman ML, Kerns SR, Hawkins IF Jr: Permanent indwelling peritoneal access device for the management of malignant ascites. Cardiovasc Intervent Radiol 1994;17:292-294.
23. Rosenblum DI, Geisinger MA, Newman JS, Boden TM, Markowitz D, Powell D, Mullen KD: Use of subcutaneous venous access ports to treat refractory ascites. J Vasc Intervent Radiol 2001;12:1343-1346.
24. Savin MA, Kirsch MJ, Romano WJ, Boden TM, Markowitz D, Powell D, Mullen KD: Peritoneal ports for treatment of intractable ascites. J Vasc Intervent Radiol 2005;16: 363-368.
25. Ozkan O, Akinci D, Gocmen R, Cil B, Ozmen M, Akhan O: Percutaneous placement of peritoneal port-catheter in patients with malignant ascites. Cardiovasc Intervent Radiol 2007;30:232-236.
26. Kurtz RC, Bronzo RL: Does spontaneous bacterial peritonitis occur in malignant ascites? Am J Gastroenterol 1982;77: 146-148.